BTN3A1 and neoplasm: In 2014, the Sandstrom group clarified the structural, biophysical, and functional methods by which the intracellular B30.2 domain of BTN3A1 detects heightened intracellular PAg concentrations (such as those accumulated during tumor development) through a highly positively charged surface pocket, with all known PAgs containing negatively charged phosphates.